NSEShareholders meeting1d ago · 17 Nov 2026, 06:14 pm
Shareholders meeting
Fischer Medical Ventures Limited · FISCHER
✦ AI SummaryResults
Fischer Medical Ventures Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. The company has informed the Exchange regarding voting results. Resolutions 1, 3, 6, and 7 have been approved by the shareholders with requisite majority.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Fischer Medical Ventures Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
Attachments (1)
📄pdf
Download →
FISCHER_17112026181330_ScrutiniserReportupload.pdf
View document text
FISCHER MEDICAL VENTURES LIMITED
Registered Office Address: Survey No. 480/2 AP Medtech Zone,
Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032
CIN: L86900AP1993PLC118162
Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548
November 17, 2026
To To
BSE Limited National Stock Exchange of India Ltd. Exchange
Corporate Relationship Department Plaza, 5tll floor
25th Floor, P J Towers Plot No. C/ 1, G Block,
Dalal Street, Fort, Bandra-Kurla Complex Bandra (E),
Mumbai – 400 001 Mumbai - 400 051
BSE Scrip Code: 524743 NSE Symbol: FISCHER
Dear Sir / Madam,
Reg : Intimation of the results of Postal Ballot as per Regulation 44(3) of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI
(LODR) 2015)
Please refer to our letter dated 14th October 2026, informing about the proposal to seek the approval of
the shareholders of the Company by way of ordinary and special resolutions, through postal ballot (e-
voting) for the following Special Business:
a) Approval for creation of security by way of first-ranking pari passu floating charge over the present
and future assets of the company’s Indian material subsidiaries in connection with the proposed
issuance of senior, secured, rated, listed, redeemable, taxable, transferable non-convertible
debentures.
b) Approval for related party transaction in connection with the proposed pledge of equity shares of
the company held by the promoters and/or holding company/promoter group company as security
for the proposed issuance of senior, secured, rated, listed, redeemable, taxable, transferable non-
convertible debentures.
c) Approval for creation of pledge over 100% of the equity shares held by the company in its key
subsidiaries (Indian material subsidiaries) in connection with the proposed issuance of senior,
secured, rated, listed, redeemable, taxable, transferable non-convertible debentures.
d) Approval for obtaining corporate guarantee from the promoter/ holding company FMV Holdings
Pte. Ltd. In connection with the proposed issuance of senior, secured, rated, listed, redeemable,
taxable, transferable non-convertible debentures.
e) Approval for obtaining corporate guarantee from promoter group company Mercatus Capital Pte.
Ltd. in connection with the proposed issuance of senior, secured, rated, listed, redeemable, taxable,
transferable non-convertible debentures.
f) Power to create charge on the assets of the company to secure borrowings pursuant to Section
180(1)(a) of The Companies Act, 2013.
g) Increase in Borrowing limit pursuant to section 180(1)(c) of The Companies Act, 2013.
Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006
FISCHER MEDICAL VENTURES LIMITED
Registered Office Address: Survey No. 480/2 AP Medtech Zone,
Nadupura Village, Pedagantyadu Mandal, Visakhapatnam, 530032
CIN: L86900AP1993PLC118162
Email: cs@fischermv.com | Website: www.fischermv.com | Contact 9080966548
Please find enclosed the details of the result of the said Postal Ballot together with the particulars of the
voting thereon as required under Clause 44 of the SEBI (Listing obligations and Disclosure Requirements)
Regulations, 2015. Also, please find attached the Scrutinizer's Report dated 17th November, 2026 pursuant
to Section 110 of the Companies Act, 2013 read with Rule 22 of the Companies (Management and
Administration) Rules, 2014.
We also wish to inform you that the resolutions 1, 3, 6 and 7 have been approved by the shareholders with
requisite majority.
Thanking You,
Yours Truly,
For FISCHER MEDICAL VENTURES LIMITED
BALAJI GANDLA
COMPANY SECRETARY & COMPLIANCE OFFICER
Corporate Office: Level 8, Prestige Palladium Bayan, No. 129-140 Greams Road, Chennai, Tamil Nadu, 600006
NUREN LODAYA & ASSOCIATES Phone Number: 7021113226
COMPANY SECRETARY Email: csnuren@gmail.com
(Peer Reviewed Firm)
Registered Address: B 403, Pranav Commercial Plaza,
MG Road, Mulund West, Mumbai 400080
SCRUTINIZER’S REPORT
[Pursuant to Sections 108 and 110 of the Companies Act, 2013 read with Rules 20 and 22 of the Companies (Management
and Administration) Rules, 2014 and Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015]
The Chairman,
Fischer Medical Ventures Limited
CIN: L86900AP1993PLC118162
Survey No. 480/2, AP Medtech Zone, Nadupura Village,
Pedagantyadu Mandal, Visakhapatnam – 530 032, Andhra Pradesh.
Sub: Scrutinizer’s Report on Postal Ballot conducted through remote e-Voting pursuant to the
Postal Ballot Notice dated 14th October, 2026
Dear Sir,
I, CS Nuren Nirmal Lodaya, Proprietor of M/s. Nuren Lodaya & Associates, Practising Company
Secretaries (FCS No. F14090, C.P. No. 24248), having office at B 403, Pranav Commercial Plaza, MG
Road, Mulund West, Mumbai – 400 080, had been appointed as Scrutinizer by the Board of Directors
of Fischer Medical Ventures Limited (CIN: L86900AP1993PLC118162) (“the Company”) at its
meeting held on 14th October, 2026, pursuant to Rule 22(5) of the Companies (Management and
Administration) Rules, 2014, as amended (“the Rules”), for conducting the Postal Ballot process
through remote e-voting in a fair and transparent manner, in respect of the resolutions set out in the
Postal Ballot Notice dated 14th October, 2026 (“the Notice”), pursuant to the provisions of Sections
108 and 110 of the Companies Act, 2013 (“the Act”) read with Rules 20 and 22 of the Rules, the
General Circulars issued by the Ministry of Corporate Affairs (“MCA Circulars”), Regulation 44 of
the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“SEBI Listing Regulations”) and the Secretarial Standard on General Meetings (SS-
The Management of the Company is responsible to ensure compliance with the requirements of the Act,
the Rules, the MCA Circulars and the SEBI Listing Regulations relating to the Postal Ballot process
and voting through electronic means on the resolutions contained in the Notice. My responsibility as
Scrutinizer is restricted to scrutinising the remote e-voting process in a fair and transparent manner, and
to making a Scrutinizer’s Report of the votes cast in favour of or against the resolutions.
I submit my report as under:
● As per the information provided by the Company, the Notice, together with the Explanatory
Statement, was sent on 16th October, 2026 through electronic mode to those Members whose
names appeared in the Register of Members / List of Beneficial Owners as on the cut-off date,
i.e. Friday, 09th October, 2026, and whose e-mail addresses were registered with the Company
/ Depositories, in accordance with Section 110 of the Act read with Rule 22 of the Rules and
the MCA Circulars. The voting rights of the Members have been reckoned in proportion to their
shareholding in the paid-up equity share capital of the Company as on the said cut-off date, one
equity share carrying one vote.
● In terms of the Notice and the MCA Circulars, the voting on the resolutions was conducted
only through remote e-voting and no physical postal ballot forms were sent or received. The
Page 1 of 10
NUREN LODAYA & ASSOCIATES Phone Number: 7021113226
COMPANY SECRETARY Email: csnuren@gmail.com
(Peer Reviewed Firm)
Registered Address: B 403, Pranav Commercial Plaza,
MG Road, Mulund West, Mumbai 400080
Company provided the facility of remote e-voting through the e-voting platform of National
Securities Depository Limited (“NSDL”) under EVEN 143338. The remote e-voting period
commenced on Saturday, 17th October, 2026 at 9:00 A.M. (IST) and ended on Sunday, 15th
November, 2026 at 5:00 P.M. (IST), and the NSDL e-voting module was disabled thereafter.
All the votes were cast within the said period.
● After the conclusion of the remote e-voting period, the votes cast through remote e-voting were
unblocked and downloaded from the e-voting system of NSDL and scrutinised by me through
the Scrutinizer’s login on the NSDL e-voting portal.
● The votes
[Showing first 8,000 characters — download PDF for full document]